Chloroquine and hydroxychloroquine retinopathy in a cohort with rheumatic diseases in Mexico: prevalence, risk factors, and retinopathy patterns
Authors:
- Karim Mohamed-NoriegaKMKarim Mohamed-Noriega
- Janett L. Riega-TorresJRJanett L. Riega-Torres
- Eduardo Alejandro Treviño-FernándezETEduardo Alejandro Treviño-Fernández
- Karina Palomo-ArnaudKPKarina Palomo-Arnaud
- Jesus Hernán González-CortésJGJesus Hernán González-Cortés
- Abraham Olvera-BarriosAOAbraham Olvera-Barrios
- Jibran Mohamed-NoriegaJMJibran Mohamed-Noriega
- Sergio Ayala-De la CruzSCSergio Ayala-De la Cruz
- Jorge A. Esquivel-ValerioJEJorge A. Esquivel-Valerio
- Fernando Morales-WongFMFernando Morales-Wong
- Dionicio Ángel Galarza-DelgadoDGDionicio Ángel Galarza-Delgado
- Jesus Mohamed-HamshoJMJesus Mohamed-Hamsho
Open Access
- 5 September 2026
- journal article
- research article
- Published by Springer Nature in Clinical Rheumatology
- Vol. 45 (11) , 7039-7050
Abstract
Introduction/objectives To compare chloroquine (CQ) and hydroxychloroquine (HCQ) retinopathy prevalence, risk factors, severity, and patterns in a cohort of Hispanic patients with rheumatic diseases in Mexico. Methods Retrospective, cross-sectional study of patients with rheumatic diseases treated with CQ/HCQ who underwent retinopathy screening (from 2014 to 2019) with macular spectral domain optical coherence tomography and automated visual field tests. The most recent screening report was included to define the presence or absence of retinopathy. Results A total of 571 patients were recruited; 27 were excluded due to missing reports. A total of 544 patients were analyzed, 26% (140/544) used CQ, and 74% (404/544) HCQ. Mean age at treatment initiation was 44.9 ± 15.8 years; 95% were female. Retinopathy prevalence was higher with CQ (19%) than HCQ (2%) (P < 0.001). This was consistent in those using antimalarials < 5 years (CQ: 8.5% vs. HCQ: 1.8%; P < 0.007) and those using antimalarials ≥ 5 years (CQ: 33% vs. HCQ: 2.4%; P < 0.001). CQ patients had more years of use at retinopathy diagnosis than HCQ patients (9.0 ± 4.3 vs. 5.1 ± 3.3, P < 0.023). Parafoveal retinopathy pattern was most frequent in patients using CQ (81%) and HCQ (100%), with no isolated perifoveal pattern. Most patients with retinopathy (59%) had a severe grade. In multivariable regression model, CQ was associated with higher odds of retinopathy compared with HCQ (OR, 12.03; 95% CI 4.41–35.74; P < 0.001). Observed independent risk factors for retinopathy were older age at treatment initiation (OR, 1.04; 95% CI 1.00–1.08; P = 0.029) and years of antimalarial use (OR, 1.18; 95% CI 1.09–1.28; P < 0.001). Conclusion CQ poses a higher risk of antimalarial retinopathy than HCQ. Older age at treatment initiation and duration of use were independent risk factors. Parafoveal was the most frequent retinopathy pattern. Key Points • Antimalarial retinopathy prevalence is significantly higher with chloroquine (19%) than with hydroxychloroquine (2%). • Chloroquine use is associated with significantly higher odds of retinopathy compared with hydroxychloroquine (OR, 12.03; 95% CI 4.41–35.74; P < 0.001). • An older age at treatment initiation (OR, 1.04; 95% CI 1.00–1.08; P = 0.029) and years of antimalarial use (OR, 1.18; 95% CI 1.09–1.28; P < 0.001) are independent risk factors for chloroquine/hydroxychloroquine retinopathy. • The most frequently observed antimalarial retinopathy pattern in this cohort of rheumatic patients in Mexico was the parafoveal (85%), with no cases of perifoveal pattern.Keywords
This publication has 20 references indexed in Scilit:
- Risk Factors for Hydroxychloroquine Retinopathy and Its SubtypesJAMA Network Open, 2024
- Are the Current Recommendations for Chloroquine and Hydroxychloroquine Screening Appropriate?Rheumatic Disease Clinics of North America, 2019
- Hydroxychloroquine Retinopathy: Drug Cessation versus Drug ContinuationOphthalmology Retina, 2019
- Hydroxychloroquine retinopathyEye, 2017
- Recommendations on Screening for Chloroquine and Hydroxychloroquine Retinopathy (2016 Revision)Ophthalmology, 2016
- Pericentral Retinopathy and Racial Differences in Hydroxychloroquine ToxicityOphthalmology, 2015
- Effect of Disease Stage on Progression of Hydroxychloroquine RetinopathyJAMA Ophthalmology, 2014
- A solution to the problem of separation in logistic regressionStatistics in Medicine, 2002
- Tissue distribution of chloroquine, hydroxychloroquine, and desethylchloroquine in the ratToxicology and Applied Pharmacology, 1967
- RETINOPATHY FOLLOWING CHLOROQUINE THERAPYThe Lancet, 1959